Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: OTC
DilutionScan read 3 of Inhibitor Therapeutics, Inc.'s SEC filings and found 2 warrant series, 3 convertibles and 1 completed offering on file for INTI. Analysis updated Aug 29, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
CALCCalciMedica, Inc.
PHIOPhio Pharmaceuticals Corp.
CLGNCollPlant Biotechnologies Ltd Ordinary Shares
INABIN8bio, Inc.
GTBPGT Biopharma, Inc.
ICUSeaStar Medical Holding Corporation
BLRXBioLineRX Ltd
PTNPalatin Technologies, Inc.
GDTCCytoMed Therapeutics Limited Ordinary Shares
PASGPassage Bio, Inc.
TVRDTvardi Therapeutics, Inc.
INTSIntensity Therapeutics, Inc.
LTRNLantern Pharma Inc.
BCLIBrainstorm Cell Therapeutics Inc.
CURXCuranex Pharmaceuticals Inc Common Stock